Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial) | Zendy

Paul K. Keith | Zendy; Caroline Koch | Zendy; Michel Djandji | Zendy; Jacques Bouchard | Zendy; Eliofotisti Psaradellis | Zendy; John S. Sampalis | Zendy; R. Robert Schellenberg | Zendy; R Andrew McIvor | Zendy

Open Access

Montelukast as Add-On Therapy with Inhaled Corticosteroids or Inhaled Corticosteroids and Long-Acting Beta-2-Agonists in the Management of Patients Diagnosed with Asthma and Concurrent Allergic Rhinitis (The RADAR Trial)

Author(s) -

Paul K. Keith,

Caroline Koch,

Michel Djandji,

Jacques Bouchard,

Eliofotisti Psaradellis,

John S. Sampalis,

R. Robert Schellenberg,

R Andrew McIvor

Publication year - 2009

Publication title -

canadian respiratory journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.675

H-Index - 53

eISSN - 1916-7245

pISSN - 1198-2241

DOI - 10.1155/2009/145071

Subject(s) - medicine , montelukast , asthma , corticosteroid , inhaled corticosteroids , quality of life (healthcare) , randomized controlled trial , observational study , physical therapy , nursing

To evaluate the effectiveness of montelukast as add-on therapy for patients diagnosed with asthma and concurrent allergic rhinitis who remain uncontrolled while receiving inhaled corticosteroid (ICS) monotherapy or ICS/long-acting beta-2-agonist (LABA) therapy in a community practice setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research